Sphera Funds Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-235,000
Closed -$4.22M 103
2019
Q1
$4.22M Buy
+235,000
New +$4.06M 0.39% 61
2018
Q2
Sell
-135,000
Closed -$3.4M 115
2018
Q1
$3.4M Sell
135,000
-3,700
-3% -$89.9K 0.52% 54
2017
Q4
$2.63M Sell
138,700
-70,000
-34% -$1.31M 0.31% 80
2017
Q3
$3.86M Buy
208,700
+127,500
+157% +$2.21M 0.55% 51
2017
Q2
$1.42M Hold
81,200
0.24% 98
2017
Q1
$1.51M Hold
81,200
0.3% 83
2016
Q4
$1.66M Sell
81,200
-48,800
-38% -$1.23M 0.42% 63
2016
Q3
$3.89M Hold
130,000
0.63% 39
2016
Q2
$3.51M Sell
130,000
-23,000
-15% -$519K 0.91% 33
2016
Q1
$2.87M Hold
153,000
0.62% 28
2015
Q4
$4.74M Sell
153,000
-17,000
-10% -$516K 0.69% 24
2015
Q3
$3.64M Buy
170,000
+85,000
+100% +$2.67M 0.46% 44
2015
Q2
$3.23M Buy
85,000
+25,000
+42% +$822K 0.32% 79
2015
Q1
$1.88M Sell
60,000
-24,198
-29% -$820K 0.2% 111
2014
Q4
$2.95M Sell
84,198
-23,583
-22% -$588K 0.5% 63
2014
Q3
$2.25M Sell
107,781
-3,219
-3% -$66.6K 0.28% 79
2014
Q2
$2.41M Buy
111,000
+70,000
+171% +$1.47M 0.59% 41
2014
Q1
$1.14M Buy
+41,000
New +$1.45M 0.26% 85

Other funds holding MGNX

Sphera Funds Management's MGNX Position: Q2 2019 in Review

Sphera Funds Management sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 235,000 shares — an estimated $4.22M sold.

Sphera Funds Management first reported a position in MGNX in Q1 2014 and held it in 18 quarters. The position peaked at $4.74M in Q4 2015. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

  • Sphera Funds Management reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
  • Sphera Funds Management sold 235,000 MacroGenics shares in Q2 2019, an estimated $4.22M.
  • Sphera Funds Management first reported a position in MacroGenics in Q1 2014 and held it in 18 quarters.
  • Sphera Funds Management's MacroGenics position peaked at $4.74M in Q4 2015.
  • 130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.